At a glance
- Originator Bayer
- Class Antibacterials; Glycolipids
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 02 Jul 1996 No-Development-Reported for Bacterial infections in Germany (Unknown route)